- Theriva Biologics closes sale of SYN-004 enzyme portfolio to Biossil Labs.
- Receives $350K upfront with eligibility for up to $91M in regulatory and sales milestones plus royalties.
- Biossil assumes all future development and commercialization expenses.
Signal #104545 · SEC 8-K
$TOVX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $TOVX filing catalyst
Why did $TOVX trigger an AI stock catalyst alert?
$TOVX triggered a Stock Catalyst AI alert on 2026-11-02 00:00:00 UTC for a SEC 8-K filing (AI Score: +2.5/10). Headline: Theriva Biologics Sells SYN-004 Portfolio for $350K Upfront, up to $91M in Milestones. Key points: - Theriva Biologics closes sale of SYN-004 enzyme portfolio to Biossil Labs. - Receives $350K upfront with eligibility for up to $91M in regulatory and sales milestones plus royalties. - Biossil assumes all future development and commercialization expenses.
How did $TOVX stock react after the SEC filing?
After the SEC 8-K for $TOVX, observed market reaction: T0 price $0.19. Past moves do not guarantee future results.
Where can I get real-time $TOVX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $TOVX via Telegram and the VIP Web Terminal from €10/month.